Daiichi Sankyo (TSE: 4568) and GENESIS Pharma have entered into an exclusive license and supply agreement for the distribution and commercialization of VANFLYTA ® (quizartinib) in 13 markets across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback